Structure of Alfuzosin HCl
CAS No.: 81403-68-1
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Alfuzosin HCl is an antagonist of α1 adrenergic receptor used to treat benign prostatic hyperplasia (BPH).
Synonyms: SL 77499-10; Alfuzosin(hydrochloride); Uroxatral
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 81403-68-1 |
Formula : | C19H28ClN5O4 |
M.W : | 425.91 |
SMILES Code : | O=C(C1OCCC1)NCCCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)C.Cl |
Synonyms : |
SL 77499-10; Alfuzosin(hydrochloride); Uroxatral
|
MDL No. : | MFCD00879135 |
InChI Key : | YTNKWDJILNVLGX-UHFFFAOYSA-N |
Pubchem ID : | 71764 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
Target |
|
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01685658 | Renal Colic A... More >>cute Renal Colic Less << | Phase 4 | Suspended(same study already p... More >>ublished) Less << | March 2018 | France ... More >> CH d'Alès Alès, France, 30103 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 Less << |
NCT01323998 | - | Completed | - | - | |
NCT01332487 | - | Completed | - | - | |
NCT01323998 | - | Completed | - | - | |
NCT01332487 | - | Completed | - | - | |
NCT01332435 | - | Completed | - | - | |
NCT01332435 | - | Completed | - | - | |
NCT01386983 | - | Completed | - | - | |
NCT00687388 | Benign Prostatic Hyperplasia | Phase 4 | Withdrawn(in order to prepare ... More >>a new clinical trial to evaluate with pathological change) Less << | - | Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Less << |
NCT00347061 | Benign Prostatic Hyperplasia | Phase 3 | Completed | - | Japan ... More >> Sanofi-Aventis Tokyo, Japan Less << |
NCT00397397 | - | Unknown | - | Israel ... More >> Hillel Yaffe Medical Center Hadera, Israel, 38100 Less << | |
NCT01435954 | - | Completed | - | - | |
NCT00451061 | Renal Colic | Phase 4 | Unknown | - | Israel ... More >> Urology department, Soroka university medical center Not yet recruiting Beer-Sheva, p,o,box 151, Israel, 84101 Less << |
NCT01386983 | - | Completed | - | - | |
NCT01390870 | - | Completed | - | - | |
NCT01390870 | - | Completed | - | - | |
NCT02266537 | Healthy | Phase 1 | Completed | - | - |
NCT02977832 | Benign Prostatic Hypertrophy W... More >>ith Outflow Obstruction Benign Prostatic Hyperplasia Less << | Not Applicable | Completed | - | Italy ... More >> Urology Department Fondazione IRCCS Policlinico San Matteo Pavia, Italy, 27100 Less << |
NCT00064649 | Benign Prostatic Hyperplasia | Phase 3 | Terminated(Inability to recrui... More >>t required sample size.) Less << | - | United States, Colorado ... More >> University of Colorado Health Sciences Center Denver, Colorado, United States, 80010 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Columbia University New York, New York, United States, 10032 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Baylor College of Medicine Houston, Texas, United States, 77030 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less << |
NCT00029822 | Urinary Retention ... More >> Prostatic Hyperplasia Benign Prostatic Hypertrophy Less << | Phase 3 | Completed | - | - |
NCT00399464 | Prostatic Hyperplasia | Phase 3 | Completed | - | Japan ... More >> Sanofi-Aventis Tokyo, Japan Less << |
NCT00409357 | Benign Prostatic Hyperplasia | Phase 2 | Completed | - | Japan ... More >> Sanofi-Aventis Tokyo, Japan Less << |
NCT00713739 | Kidney Stones | Phase 3 | Unknown | December 2012 | United States, California ... More >> Naval Medical Center San Diego Recruiting San Diego, California, United States, 92134 Contact: Brian K Auge, M.D. 619-532-7200 Contact: Sean P. Stroup, M.D. 619-532-7200 Principal Investigator: Brian K. Auge, M.D. Principal Investigator: Sean P. Stroup, M.D. Less << |
NCT00201630 | Prostate Cancer | Phase 3 | Unknown | - | United States, New York ... More >> New York Prostate Institute Recruiting Oceanside, New York, United States, 11572 Contact: Betsy Guzman 516-632-3370 bguzman@snch.org Principal Investigator: Louis Potters, MD Less << |
NCT00264017 | - | Completed | - | United States, Florida ... More >> Dattoli Cancer Center and Brachytherapy Research Institute Sarasota, Florida, United States, 34237 Less << | |
NCT00427882 | Prostatic Hyperplasia | Phase 4 | Completed | - | Korea, Republic of ... More >> Handok Seoul, Korea, Republic of Less << |
NCT00540891 | Benign Prostatic Hyperplasia | Phase 3 | Completed | - | United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less << |
NCT01418599 | Healthy | Phase 1 | Completed | - | India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd., Village Bhat, Gandhinagar, Gujarat, India, 382428 Less << |
NCT01418586 | Healthy | Phase 1 | Completed | - | India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd., Village Bhat, Gandhinagar, Gujarat, India, 382428 Less << |
NCT00563654 | Prostatic Hyperplasia ... More >> Urinary Retention Acute Disease Less << | Not Applicable | Terminated | - | China ... More >> North District Hospital Hong Kong, China Less << |
NCT00280605 | Prostatic Hyperplasia | Phase 4 | Completed | - | - |
NCT00629720 | Urinary Bladder Neurogenic | Phase 3 | Completed | - | United States, Pennsylvania ... More >> Sanofi-Aventis Administrative Office Malvern, Pennsylvania, United States, 19355 Serbia Sanofi-Aventis Administrative Office Belgrade, Serbia Less << |
NCT00583258 | Kidney Stones | Not Applicable | Withdrawn | - | Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less << |
NCT00542165 | BPH/LUTS/Sexual Functions | Phase 4 | Completed | - | Korea, Republic of ... More >> Sanofi-Aventis Seoul, Korea, Republic of Less << |
NCT00453908 | Urinary Retention | Phase 3 | Terminated(The study was early... More >> terminated due to slow and difficult recruitment) Less << | - | Denmark ... More >> Sanofi-Aventis Hoersholm, Denmark Less << |
NCT01834729 | Constipation | Phase 2 | Completed | - | United States, Minnesota ... More >> Mayo Clinic Rochester Rochester, Minnesota, United States, 55905 Less << |
NCT00409227 | Urolithiasis ... More >>Nephrolithiasis Ureterolithiasis Less << | Phase 2 | Unknown | - | Israel ... More >> Endourology unit Urology department Assaf Harofeh MC Recruiting Zerifin, Israel, 40700 Contact: yoram i siegel, MD 972-577-345408 ysiegel@asaf.health.gov.il Principal Investigator: yoram i siegel, MD Sub-Investigator: yaniv shilo, MD Less << |
NCT00941343 | Prostatic Diseases | Not Applicable | Completed | - | Taiwan ... More >> Sanofi-Aventis Administrative Office Taipei, Taiwan Less << |
NCT00336921 | Acute Urinary Retention | Phase 2 | Completed | - | China ... More >> Sanofi-aventis Beijing, China Less << |
NCT00549939 | Neurogenic Urinary Bladder | Phase 3 | Completed | - | - |
NCT00256399 | BPH Erectile ... More >>Dysfunction Less << | Not Applicable | Unknown | - | United States, Ohio ... More >> University Hospitals of Cleveland Recruiting Cleveland, Ohio, United States, 44106 Contact: Ann M Serenko, MS, RN 216-844-3515 ann.serenko@uhhs.com Contact: Allen D Seftel, MD 216-844-7728 adseftel@aol.com Principal Investigator: Allen D Seftel, MD Sub-Investigator: Martin Resnick, MD Sub-Investigator: Donald Bodner, MD Less << |
NCT00454402 | Prostatic Hyperplasia | Phase 3 | Terminated(Discontinued due to... More >> incomplete recruitment) Less << | - | Portugal ... More >> Sanofi-Aventis Lisbon, Portugal Less << |
NCT00549939 | - | Completed | - | - | |
NCT00290030 | Prostatic Hyperplasia ... More >> Acute Urinary Retention Less << | Phase 3 | Completed | - | - |
NCT00401661 | Prostatic Hyperplasia | Phase 4 | Completed | - | Thailand ... More >> Sanofi-Aventis Bangkok, Thailand Less << |
NCT00486785 | Prostatic Hyperplasia | Phase 4 | Completed | - | Colombia ... More >> Sanofi-Aventis Bogota, Colombia Ecuador Sanofi-Aventis Quito, Ecuador Guatemala Sanofi-Aventis Guatemala City, Guatemala Mexico Sanofi-Aventis Mexico, Mexico Less << |
NCT00637715 | Benign Prostatic Hyperplasia | Phase 4 | Completed | - | Hungary ... More >> Sanofi-Aventis Budapest, Hungary Less << |
NCT00103402 | Prostatitis | Phase 3 | Completed | - | United States, California ... More >> David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095 Stanford University Medical Center Stanford, California, United States, 94305 United States, Illinois Northwestern U. Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Massachusetts Harvard Medical School- Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania Temple University Philadelphia, Pennsylvania, United States, 19140 United States, Washington University of Washington- Harborview Medical Center Seattle, Washington, United States, 98108 Canada, Ontario Queen's University Kingston, Ontario, Canada, K7L 3N6 Less << |
NCT00696761 | BPH | Phase 4 | Completed | - | - |
NCT00836823 | Benign Prostatic Hyperplasia ... More >> Lower Urinary Tract Symptoms Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Asan Medical Center, Ulsan College of Medicine Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Less << |
NCT00576823 | Hydronephrosis ... More >> Neurogenic Bladder Less << | Phase 3 | Completed | - | Bulgaria ... More >> Sanofi-Aventis Administrative Office Sofia, Bulgaria Canada Sanofi-Aventis Administrative Office Laval, Canada Estonia Sanofi-Aventis Administrative Office Tallin, Estonia India Sanofi-Aventis Administrative Office Mumbai, India Malaysia Sanofi-Aventis Administrative Office Kuala Lumpur, Malaysia Poland Sanofi-Aventis Administrative Office Warszawa, Poland Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Serbia Sanofi-Aventis Administrative Office Belgrade, Serbia Singapore Sanofi-Aventis Aministrative Office Singapore, Singapore Slovakia Sanofi-Aventis Administrative Office Bratislava, Slovakia Taiwan Sanofi-Aventis Administrative Office Taipei, Taiwan Turkey Sanofi-Aventis Administrative Office Istanbul, Turkey Less << |
NCT00696761 | - | Completed | - | - | |
NCT00576823 | - | Completed | - | - | |
NCT00575913 | Prostatic Diseases | Phase 4 | Completed | - | Thailand ... More >> Sanofi-Aventis Bangkok, Thailand Less << |
NCT00893113 | - | Completed | - | - | |
NCT00688948 | Multiple Sclerosis ... More >> Bladder Dysfunction Less << | Phase 2 Phase 3 | Terminated(Lack of funding) | - | Canada, Nova Scotia ... More >> QE II Health Science Centre, Halifax Infirmary Halifax, Nova Scotia, Canada, B3H 3A7 Less << |
NCT00679315 | Voiding Dysfunction | Phase 2 | Completed | - | Korea, Republic of ... More >> Chungnam National University Hospital Daejeon, Korea, Republic of Holy Family Hospital, The Catholic University of Korea Kyonggi-do, Korea, Republic of, 420-717 Pusan National University Hospital Pusan, Korea, Republic of, 602-739 Cheil General Hospital & Women's Healthcare Center, College of Medicine, Kwandong University Seoul, Korea, Republic of, 100-380 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Anam Hospital, College of Medicine, Korea University Seoul, Korea, Republic of, 136-705 Kangnam St. Mary's Hospital, The Catholic University of Korea Seoul, Korea, Republic of, 137-701 Asan Medical Center, Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less << |
NCT00893113 | Erectile Dysfunction ... More >> Lower Urinary Tract Symptoms Less << | Phase 3 | Completed | - | United States, Maryland ... More >> Chesapeake Urology Research Associates Baltimore, Maryland, United States, 21204 Chesapeake Urology Research Associates Baltimore, Maryland, United States, 21237 Chesapeake Urology Research Associates Glen Burnie, Maryland, United States, 21061 Chesapeake Urology Research Associates Towson, Maryland, United States, 21204 Less << |
NCT03144596 | Benign Prostatic Hyperplasia ... More >> Pupil Anomaly Choroid Disease Less << | Phase 4 | Completed | - | - |
NCT00388271 | Urinary Calculi | Phase 3 | Withdrawn(lack of funding) | - | Singapore ... More >> Urology Centre Singapore, Singapore Less << |
NCT00467467 | Ureteral Stent Discomfort | Phase 3 | Completed | - | United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less << |
NCT00177086 | Kidney Calculi ... More >> Ureteral Calculi Colic Less << | Phase 3 | Completed | - | United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.35mL 0.47mL 0.23mL |
11.74mL 2.35mL 1.17mL |
23.48mL 4.70mL 2.35mL |
|
Dissolving Methods |
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
|